Stuart J Schnitt Selected Research

Stuart J Schnitt Research Topics

Disease

76	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2002
57	Neoplasms (Cancer) 12/2023 - 01/2002
30	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2022 - 09/2002
10	Triple Negative Breast Neoplasms 01/2022 - 07/2009
8	Breast Diseases (Breast Disease) 01/2017 - 06/2003
6	Carcinoma (Carcinomatosis) 01/2020 - 01/2002
5	Lobular Carcinoma 04/2024 - 07/2013
4	Breast Carcinoma In Situ 10/2022 - 10/2013
4	Pathologic Complete Response 01/2021 - 02/2007
4	Carcinogenesis 01/2017 - 01/2010
2	Residual Neoplasm 11/2022 - 11/2022
2	Hyperplasia 03/2022 - 03/2021
2	Intraductal Papilloma 01/2020 - 08/2006
2	Papillary Carcinoma 01/2020 - 08/2006
2	Necrosis 01/2018 - 12/2009
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017 - 04/2016
2	Ductal Carcinoma 01/2016 - 05/2004
2	Margins of Excision 07/2012 - 01/2010
1	Mucocele 01/2022
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2022
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2020
1	Acinar Cell Carcinoma 01/2017
1	Confusion (Bewilderment) 07/2013
1	Weight Gain 01/2012

Drug/Important Bio-Agent (IBA)

30	Estrogen ReceptorsIBA 01/2024 - 10/2004
18	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2006
16	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 10/2004
11	Phenobarbital (Luminal)FDA Link 12/2023 - 01/2008
10	Hormones (Hormone)IBA 01/2023 - 01/2006
9	Proteins (Proteins, Gene)FDA Link 04/2024 - 03/2004
8	human ERBB2 proteinIBA 01/2023 - 02/2007
6	Cadherins (E-Cadherin)IBA 04/2024 - 07/2013
6	Tamoxifen FDA LinkGeneric 01/2019 - 05/2005
6	ParaffinIBA 01/2018 - 01/2005
5	AntibodiesIBA 01/2024 - 05/2006
5	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 04/2011
4	ORALIT (ORS)IBA 03/2021 - 04/2009
4	ErbB Receptors (EGF Receptor)IBA 10/2012 - 07/2009
4	Keratins (Keratin)IBA 02/2011 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 01/2010
2	MucinsIBA 10/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2020 - 10/2016
2	Monoclonal AntibodiesIBA 01/2020 - 12/2019
2	AndrogensIBA 01/2019 - 02/2014
2	Formaldehyde (Formol)FDA Link 01/2018 - 01/2015
2	Estrogens (Estrogen)FDA Link 02/2014 - 10/2004
2	Vitamin D FDA LinkGeneric 02/2014 - 07/2012
2	Messenger RNA (mRNA)IBA 11/2011 - 01/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 01/2002
2	CalponinsIBA 02/2009 - 08/2006
2	Myosin Heavy Chains (Myosin Heavy Chain)IBA 02/2009 - 08/2006
2	Trastuzumab (Herceptin)FDA Link 02/2007 - 03/2004
1	SolutionsIBA 12/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	cabozantinibIBA 08/2021
1	NivolumabIBA 08/2021
1	Platinum Compounds (Compounds, Platinum)IBA 10/2020
1	Cisplatin (Platino)FDA LinkGeneric 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	atezolizumabIBA 01/2020
1	Retinoblastoma ProteinIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2019
1	Aromatase InhibitorsIBA 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2018
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2018
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 11/2017
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Polycomb-Group ProteinsIBA 01/2017
1	B7-H1 AntigenIBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2015
1	N 30IBA 01/2015
1	MicronutrientsIBA 01/2015
1	Histones (Histone)IBA 10/2014
1	Lysine (L-Lysine)FDA Link 10/2014
1	CateninsIBA 07/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2012
1	CalciumIBA 07/2012
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2012
1	Indicators and Reagents (Reagents)IBA 11/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2011
1	N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA 07/2011

Therapy/Procedure

30	Therapeutics 11/2022 - 03/2004
19	Segmental Mastectomy (Lumpectomy) 10/2020 - 09/2002
7	Radiotherapy 01/2020 - 05/2005
6	Neoadjuvant Therapy 11/2022 - 07/2019
3	Drug Therapy (Chemotherapy) 11/2022 - 07/2011
3	Aftercare (After-Treatment) 07/2009 - 09/2002
2	Contraindications 11/2022 - 11/2022
1	Conservative Treatment 03/2022
1	Lymph Node Excision (Lymph Node Dissection) 11/2019
1	Precision Medicine 10/2017
1	Punctures 01/2015
1	Ovariectomy (Oophorectomy) 07/2014